Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2025-12-26 @ 3:04 AM
Study NCT ID:
NCT03987620
Status:
COMPLETED
Last Update Posted:
2021-09-08
First Post:
2019-06-12
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis
Sponsor:
Scynexis, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-07
Start Date Type:
ACTUAL
Primary Completion Date:
2020-03-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-04-29
Completion Date Type:
ACTUAL
First Submit Date:
2019-06-12
First Submit QC Date:
None
Study First Post Date:
2019-06-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-06-30
Results First Submit QC Date:
None
Results First Post Date:
2021-09-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2021-09-08
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-08-11
Last Update Post Date:
2021-09-08
Last Update Post Date Type:
ACTUAL